Home The Word Brain My Amedeo FAQ Privacy About   

2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.

  Pain Management

  Free Subscription

Articles published in Cephalalgia

Retrieve available abstracts of 45 articles:
HTML format

Single Articles

    January 2024
  1. STRABURZYNSKI M, M Agius A, Boczarska-Jedynak M, Brozek-Madry E, et al
    The midfacial segment pain: little known disorder in need of scientific evaluation.
    Cephalalgia. 2024;44:3331024231226176.
    PubMed     Abstract available

    December 2023
  2. BASEDAU H, Ornello R, Matteis E, Davaasuren B, et al
    Placebo and nocebo in the treatment of migraine: How much does real world effectiveness depend on contextual effects?
    Cephalalgia. 2023;43:3331024231218392.
    PubMed     Abstract available

    August 2023
  3. MAY A, Benoliel R, Imamura Y, Pigg M, et al
    Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes.
    Cephalalgia. 2023;43:3331024231187160.
    PubMed     Abstract available

    July 2023
  4. JAMTOY KA, Thorstensen WM, Stovner LJ, Rosen A, et al
    Onabotulinum toxin A block of the sphenopalatine ganglion in patients with persistent idiopathic facial pain: a randomized, triple-blind, placebo-controlled, exploratory, cross-over study.
    Cephalalgia. 2023;43:3331024231187132.
    PubMed     Abstract available

    February 2023
  5. MEISE R, Carvalho GF, Thiel C, Luedtke K, et al
    Additional effects of pain neuroscience education combined with physiotherapy on the headache frequency of adult patients with migraine: A randomized controlled trial.
    Cephalalgia. 2023;43:3331024221144781.
    PubMed     Abstract available

    January 2023
  6. FURIA A, Liguori R, Donadio V
    Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature.
    Cephalalgia. 2023;43:3331024221133386.
    PubMed     Abstract available

    November 2022
  7. CLAUSEN TC, Greve NK, Muller KI, Kristoffersen ES, et al
    Telemedicine in headache care: A systematic review.
    Cephalalgia. 2022;42:1397-1408.
    PubMed     Abstract available

    October 2022
  8. NAVRATILOVA E, Oyarzo J, Anderson T, Broide RS, et al
    Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache.
    Cephalalgia. 2022;42.
    PubMed     Abstract available

  9. SCHWEDT TJ, Tassorelli C, Silberstein SD, Szperka CL, et al
    Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1(st) edition.
    Cephalalgia. 2022;42.
    PubMed     Abstract available

    September 2022
  10. LISICKI M, Souza MNP, de Oliveira AB, Rubio-Beltran E, et al
    Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America.
    Cephalalgia. 2022;42:1086-1090.
    PubMed     Abstract available

  11. KELLIER DJ, Marquez de Prado B, Haagen D, Grabner P, et al
    Development of a text message-based headache diary in adolescents and children.
    Cephalalgia. 2022;42:1013-1021.
    PubMed     Abstract available

  12. UNAL-CEVIK I, Uluduz D, Ozge A
    A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients.
    Cephalalgia. 2022;42:1091-1092.

    August 2022
  13. THUNSTEDT DC, Schmutzer M, Fabritius MP, Thorsteinsdottir J, et al
    Headache characteristics and postoperative course in Chiari I malformation.
    Cephalalgia. 2022;42:879-887.
    PubMed     Abstract available

    July 2022
  14. OLESEN J
    Personal view: Modelling pain mechanisms of migraine without aura.
    Cephalalgia. 2022 Jul 7:3331024221111529. doi: 10.1177/03331024221111529.
    PubMed     Abstract available

  15. MYERS KA, Barmherzig R, Raj NR, Berrahmoune S, et al
    The spectrum of indomethacin-responsive headaches in children and adolescents.
    Cephalalgia. 2022;42:793-797.
    PubMed     Abstract available

    June 2022
  16. MAKAREVICIUS G, Ryliskiene K
    Successful treatment of primary headache associated with sexual activity using erenumab: Case report.
    Cephalalgia. 2022;42:680-683.
    PubMed     Abstract available

    May 2022
  17. NOSER AE, Klages KL, Gamwell KL, Brammer CN, et al
    A systematic evaluation of primary headache management apps leveraging behavior change techniques.
    Cephalalgia. 2022;42:510-523.
    PubMed     Abstract available

  18. CHIANG CC, Shahid AH, Harriott AM, Tietjen GE, et al
    Evaluation and treatment of headache associated with moyamoya disease - a narrative review.
    Cephalalgia. 2022;42:542-552.
    PubMed     Abstract available

    April 2022
  19. YANG S, Exposto FG, Mahmoodi S, Svensson P, et al
    Mechanical sensitivity changes in pericranial muscles after local anesthesia and experimentally induced pain in the temporalis tendon: Implications for headache and facial pain.
    Cephalalgia. 2022 Apr 26:3331024221094294. doi: 10.1177/03331024221094294.
    PubMed     Abstract available

  20. PAN LH, Wang YF, Ling YH, Lai KL, et al
    Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study.
    Cephalalgia. 2022 Apr 11:3331024221080572. doi: 10.1177/03331024221080572.
    PubMed     Abstract available

    March 2022
  21. FERNANDEZ-DE-LAS-PENAS C, Navarro-Santana MJ, Curiel-Montero F, Plaza-Manzano G, et al
    Localized and widespread pressure pain hypersensitivity in patients with episodic or chronic migraine: A systematic review and meta-analysis.
    Cephalalgia. 2022 Mar 25:3331024221084217. doi: 10.1177/03331024221084217.
    PubMed     Abstract available

  22. BUTT JH, S Eddelien H, Kruuse C
    The headache and aura-inducing effects of sildenafil in patients with migraine with aura.
    Cephalalgia. 2022 Mar 25:3331024221088998. doi: 10.1177/03331024221088998.
    PubMed     Abstract available

  23. MAYER-SUESS L, Frank F, Toll T, Boehme C, et al
    Head/neck pain characteristics after spontaneous cervical artery dissection in the acute phase and on a long-run.
    Cephalalgia. 2022 Mar 18:3331024221079298. doi: 10.1177/03331024221079298.
    PubMed     Abstract available

  24. MILOSEVIC N, Trajkovic JZ, Mijajlovic M, Milosevic J, et al
    The burden and health care use of patients with migraine and tension-type headache in post-conflict area of Serbia.
    Cephalalgia. 2022 Mar 18:3331024221082061. doi: 10.1177/03331024221082061.
    PubMed     Abstract available

  25. VAZ JM, Alves BM, Duarte DB, Marques LA, et al
    Quality appraisal of existing guidelines for the management of headache disorders by the AGREE II's method.
    Cephalalgia. 2022;42:239-249.
    PubMed     Abstract available

  26. BONIFACIO GV, Gil-Gouveia R
    Update on "Treatment of orthostatic headache without intracranial hypotension: A case report" - nine years later.
    Cephalalgia. 2022;42:273-275.
    PubMed     Abstract available

    February 2022
  27. MATAMALA-GOMEZ M, Bottiroli S, Sances G, Allena M, et al
    Facial expressions modulate pain perception in patients with chronic migraine.
    Cephalalgia. 2022 Feb 15:3331024221075081. doi: 10.1177/03331024221075081.
    PubMed     Abstract available

  28. AL-KHAZALI HM, Younis S, Al-Sayegh Z, Ashina S, et al
    Prevalence of neck pain in migraine: A systematic review and meta-analysis.
    Cephalalgia. 2022 Feb 15:3331024211068073. doi: 10.1177/03331024211068073.
    PubMed     Abstract available

  29. TAN HL, Smith JG, Hoffmann J, Renton T, et al
    A systematic review of treatment for patients with burning mouth syndrome.
    Cephalalgia. 2022;42:128-161.
    PubMed     Abstract available

    November 2021
  30. DRUMMOND PD, Finch PM
    Co-morbidity between trigeminal autonomic cephalalgias and complex regional pain syndrome: Two case reports.
    Cephalalgia. 2021 Nov 17:3331024211058204. doi: 10.1177/03331024211058204.
    PubMed     Abstract available

  31. NEVERDAHL JP, Uglem M, Matre D, Hansen JO, et al
    Pain thresholds and suprathreshold pain after sleep restriction in migraine - A blinded crossover study.
    Cephalalgia. 2021 Nov 17:3331024211056565. doi: 10.1177/03331024211056565.
    PubMed     Abstract available

    October 2021
  32. REUTER U, Krege JH, Lombard L, Gomez Valderas E, et al
    Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study.
    Cephalalgia. 2021 Oct 13:3331024211048507. doi: 10.1177/03331024211048507.
    PubMed     Abstract available

    September 2021
  33. VAN COEVORDEN MH, Schoofs MW, Venhovens J
    Paroxysmal localized Hyperhidrosis, a case-report: When excessive sweating occurs in combination with severe headaches.
    Cephalalgia. 2021;41:1124-1127.
    PubMed     Abstract available

    August 2021
  34. LIPTON RB, Dodick DW, Kudrow D, Reuter U, et al
    Reduction in migraine pain intensity in patients treated with erenumab: A post hoc analysis of two pivotal randomized studies.
    Cephalalgia. 2021 Aug 18:3331024211028966. doi: 10.1177/03331024211028966.
    PubMed     Abstract available

  35. MARTINELLI D, Arceri S, De Icco R, Allena M, et al
    BoNT-A efficacy in high frequency migraine: an open label, single arm, exploratory study applying the PREEMPT paradigm.
    Cephalalgia. 2021 Aug 18:3331024211034508. doi: 10.1177/03331024211034508.
    PubMed     Abstract available

  36. REIDY BL, Peugh J, Hershey AD, Coffey CS, et al
    Trajectory of treatment response in the child and adolescent migraine prevention (CHAMP) study: A randomized clinical trial.
    Cephalalgia. 2021 Aug 17:3331024211033551. doi: 10.1177/03331024211033551.
    PubMed     Abstract available

    July 2021
  37. EXPOSTO FG, Renner N, Bendixen KH, Svensson P, et al
    Pain in the temple? Headache, muscle pain or both: A retrospective analysis.
    Cephalalgia. 2021 Jul 18:3331024211029234. doi: 10.1177/03331024211029234.
    PubMed     Abstract available

    June 2021
  38. GERSTL L, Tadych N, Heinen F, Kainz C, et al
    Migraine and the development of additional psychiatric and pain disorders in the transition from adolescence to adulthood.
    Cephalalgia. 2021 Jun 23:3331024211021792. doi: 10.1177/03331024211021792.
    PubMed     Abstract available

  39. FRESE A, Summ O, Evers S
    CGRP release in an experimental human trigeminal pain model.
    Cephalalgia. 2021 Jun 20:3331024211017250. doi: 10.1177/03331024211017250.
    PubMed     Abstract available

    May 2021
  40. SCHWEDT TJ, Sahai-Srivastava S, Murinova N, Birlea M, et al
    Determinants of pain interference and headache impact in patients who have chronic migraine with medication overuse: Results from the MOTS trial.
    Cephalalgia. 2021 May 2:3331024211006903. doi: 10.1177/03331024211006903.
    PubMed     Abstract available

    April 2021
  41. RAOOF N, Hoffmann J
    Diagnosis and treatment of idiopathic intracranial hypertension.
    Cephalalgia. 2021;41:472-478.
    PubMed     Abstract available

  42. SORNES EO, Risal A, Manandhar K, Thomas H, et al
    Use of medicinal plants for headache, and their potential implication in medication-overuse headache: Evidence from a population-based study in Nepal.
    Cephalalgia. 2021;41:561-581.
    PubMed     Abstract available

    January 2021
  43. QAISER S, Hershey AD, Kacperski J
    SUNCT/SUNA in children and adolescents: Application of ICHD-3 criteria and treatment response: Case series of 13 SUNCT/SUNA pediatric cases.
    Cephalalgia. 2021;41:112-116.
    PubMed     Abstract available

    November 2020
  44. GOADSBY PJ, Blumenfeld AM, Lipton RB, Dodick DW, et al
    Time course of efficacy of ubrogepant for the acute treatment of migraine: Clinical implications.
    Cephalalgia. 2020 Nov 26:333102420970523. doi: 10.1177/0333102420970523.
    PubMed     Abstract available

    August 2020
  45. SCHWARZ A, Ziegeler C, Daneshkhah S, May A, et al
    Predicting the outcome of the greater occipital nerve block - an observational study on migraine patients with and without musculoskeletal cervical impairment.
    Cephalalgia. 2020 Aug 31:333102420954518. doi: 10.1177/0333102420954518.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Pain Management is free of charge.